Syngene schedules investor meeting with Franklin Templeton AMC

Syngene International Limited, a leading contract research organization, has scheduled a virtual one-to-one meeting with Franklin Templeton AMC on December 18, 2025, at 3:30 PM IST. The meeting, which will take place in Bengaluru, is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company explicitly stated that no unpublished price sensitive information (UPSI) will be disclosed during this upcoming analyst/investor meeting. This commitment underscores Syngene's adherence to regulatory transparency and fair disclosure practices, ensuring that all investors have access to the same information.

Details regarding this meeting will also be made available on the company's official website, www.syngeneintl.com. The announcement was formally communicated by Chethan Yogesh, company secretary & compliance officer, and addressed to both BSE Limited and the National Stock Exchange of India Limited. Syngene International Limited is based at Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India.